GLPG
Galapagos

1,842
Loading...
Loading...
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
704

Frequently Asked Questions

What is Market Cap of Galapagos NV - ADR?
What is the 52-week high for Galapagos NV - ADR?
What is the 52-week low for Galapagos NV - ADR?
What is Galapagos NV - ADR stock price today?
What was Galapagos NV - ADR stock price yesterday?
What is the PE ratio of Galapagos NV - ADR?
What is the Price-to-Book ratio of Galapagos NV - ADR?
What is the 50-day moving average of Galapagos NV - ADR?
How many employess does Galapagos NV - ADR has?

Latest GLPG News

View

Advertisement. Remove ads.

Advertisement. Remove ads.